Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the exchanges about its upcoming schedule of analyst and institutional investor meetings under SEBI Regulation 30. On 25 June 2025, the company will participate in the Nuvama Specialty Chemicals & Healthcare Day in Mumbai, with both group and one-on-one physical meeting formats. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. The schedule is subject to change due to exigencies. The intimation was signed by Anoop Deshpande, Company Secretary and Compliance Officer.
This is a routine investor engagement disclosure with no material business update, so it is unlikely to move the stock price. It simply signals that Sun Pharma management is actively engaging with the analyst and investor community.